Preview Mode Links will not work in preview mode

Evidence and experts to help you understand today’s public health news—and what it means for tomorrow.

Oct 27, 2021

Where are we now on combating mis- and disinformation about COVID and vaccines that has run rampant online since the early days of the pandemic? Clint Watts and Rachel Chernaskey of Miburo, a digital consulting company that focuses on misinformation and extremism, talk with Dr. Josh Sharfstein about the current...


Oct 25, 2021

Across the US, 84% of residents in nursing homes and long-term care facilities are vaccinated for COVID-19, but only 64% of staff. Federal mandates could help but it’s unclear when or how those would be enforced and, in the meantime, the industry is already suffering from a severe staffing shortage. Dr....


Oct 22, 2021

At this point in the pandemic, what do we need to know about masks? Dr. Amesh Adalja from the Center for Health Security talks with Stephanie Desmon about a new report, “Masks and Respirators for the 21st Century: Policy Changes Needed to Save Lives and Prevent Societal Disruption.” They talk about which masks are...


Oct 18, 2021

School closures and unprecedented screen time may be contributing to vision problems for kids. Pediatric ophthalmologist Dr. Megan Collins talks with Dr. Josh Sharfstein about a rise in near-sightedness in children, why vision problems are often missed without school screenings, potential health and learning effects,...


Oct 13, 2021

This week, Merck applied for FDA Emergency Use Authorization for its COVID-19 oral antiviral drug, molnupiravir. Dr. Carl Dieffenbach, director of the Division of AIDS at the National Institute of Allergy and Infectious Diseases, talks with Stephanie Desmon about how the drug works to help people recover from...